Circulating interleukin-39 as a potential biomarker for rheumatoid arthritis diagnosis
- 25 July 2023
- journal article
- research article
- Published by Elsevier in Clinical Biochemistry
- Vol. 119, 110616
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Distinct Effects of Methotrexate and Etanercept on the B Cell Compartment in Patients With Juvenile Idiopathic ArthritisArthritis & Rheumatology, 2014
- In vivo action of IL-27: reciprocal regulation of Th17 and Treg cells in collagen-induced arthritisExperimental & Molecular Medicine, 2013
- Possible roles of IL-12-family cytokines in rheumatoid arthritisNature Reviews Rheumatology, 2012
- Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatmentNature Reviews Rheumatology, 2012
- IL-12 family cytokines: immunological playmakersNature Immunology, 2012
- The environment, geo-epidemiology, and autoimmune disease: Rheumatoid arthritisAutoimmunity Reviews, 2010
- IL‐23 in the Pathogenesis of Rheumatoid ArthritisScandinavian Journal of Immunology, 2010
- Abundant expression of the interleukin (IL)23 subunit p19, but low levels of bioactive IL23 in the rheumatoid synovium: differential expression and Toll-like receptor-(TLR) dependent regulation of the IL23 subunits, p19 and p40, in rheumatoid arthritisAnnals of the Rheumatic Diseases, 2009
- Interleukin-17 gene expression in patients with rheumatoid arthritisModern Rheumatology, 2008
- Autoimmune Mechanisms Involved in the Pathogenesis of Rheumatoid ArthritisAdvances in Dental Research, 1996